XL-protein is a German biotech company commercializing its ground-breaking PASylation® technology, which enables the design of biopharmaceuticals with extended plasma half-life and enhanced action. Based on a strong proprietary technology position, XL-protein focuses at the preclinical as well as clinical development of PASylated proteins in diverse disease areas. XL-protein is engaged in a growing number of partnerships with international pharmaceutical and biotech companies at various levels. For more information, please visit: www.xl-protein.com
Karolinska Institutet is one of the world’s leading medical universities, with a vision to advance knowledge about life and strive towards better health for all. Karolinska Institutet is Sweden’s single largest centre of medical academic research. Since 1901 the Nobel Assembly at Karolinska Institutet has selected the Nobel laureates in Physiology or Medicine. Please visit: www.ki.se/en
Pharmaron is a cutting-edge, fully integrated pharmaceutical R&D service platform supporting the life science industry with operations in the U.S., China, and the UK. Please visit: www.pharmaron.com
Copyright © 2023 Antlia Bioscience, Inc. - All Rights Reserved.